← All trials
NCT04972175
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 20, 2021
- Primary completion
- Jan 31, 2022
- Completion date
- Jan 31, 2022
- First posted
- Jul 22, 2021
- Last posted
- Jul 28, 2021
- Enrollment
- 16
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Applied Medical Informatics Research Inc.Lead sponsor
- AdociaCollaborator
- Applied Medical Informatics Research Inc.Sponsor investigator
- Applied Medical Informatics Research Inc.Overall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.